Dernières nouvelles pour Abound Energy (OTC:ZAIRF) Stock

Abound Energy Inc is a development-stage company and is in the process of developing zinc-air batteries. It is a technology-first company and a leader in Zinc-air battery technology, focusing on long-duration energy storage.

Abound Energy Inc

<p>Reliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RS#NYSE">RS</a>) reported quarterly earnings of $3.77 per share which beat the analyst consensus estimate of $3.66 by 3.01 percent. This is a 28.87 percent decrease over earnings of $5.30 per share from the same period last year.  The company reported quarterly sales of $3.48 billion which beat the analyst consensus estimate of $3.45 billion by 1.15 percent.  This is a 4.40 percent decrease over sales of $3.65 billion the same period last year.</p>


Earnings

Earnings Beats

News

Reliance Q1 Adj. EPS $3.77 Beats $3.66 Estimate, Sales $3.48B Beat $3.45B Estimate

JACK

Trading Halt: Halted at 4:05:00 p.m. ET - Trading Halt: Halt News Pending

<p>Goosehead Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) affirms FY2025 sales outlook from $350.00 million-$385.00 million to $350.00 million-$385.00 million vs $371.99 million estimate.</p>


Guidance

GSHD

Goosehead Insurance Affirms FY2025 Sales Guidance of $350.00M-$385.00M vs $371.99M Est

WIIM

Texas Instruments shares are trading higher after the company reported Q1 financial results and beat its EPS and sales estimates. Additionally, the company issued Q2 sales guidance above estimates.

<p>SEI Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEIC#NASDAQ">SEIC</a>) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $1.13 by 3.54 percent. This is a 18.18 percent increase over earnings of $0.99 per share from the same period last year.  The company reported quarterly sales of $551.34 million which beat the analyst consensus estimate of $547.66 million by 0.67 percent.  This is a 7.77 percent increase over sales of $511.58 million the same period last year.</p>


SEIC

SEI Inv Q1 EPS $1.17 Beats $1.13 Estimate, Sales $551.34M Beat $547.66M Estimate

<p>BofA Securities analysts John Murphy and Federico Merendi shared their thoughts on <a href="https://www.benzinga.com/topic/mobility">the automotive industry </a>on Wednesday, after organizing the Global Automotive Summit on April 15-16.</p>
<p>Tariffs are expected to pose challenges for automakers, with more updates anticipated as <strong>Ford Motor Co</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and <strong>General Motors Co</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) release their first-quarter earnings, the analysts said.</p>
<p>Ford emphasized the need to compete more effectively with Chinese electric vehicle (EV) manufacturers, who lead in battery innovation and rapid model development. </p>
<p>While exploring potential partnerships, Ford is advancing its low-cost EV efforts through its Skunkworks initiative and expanding high-margin, stable subscription revenue from connected vehicles, with over 650,000 current subscribers, the analysts noted.</p>
<p>GM plans to leverage Cadillac's legacy further with participation in Formula One as a global growth strategy. Separately, <strong>Rivian Automotive Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) outlined its ongoing collaboration with <strong>Volkswagen AG</strong> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) and its focus on cost reduction and brand visibility.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/news/earnings/25/04/44949808/zyn-gum-makers-smoke-free-business-revenue-jumps-15-raises-annual-profit-outlook">Zyn Gum Maker&#8217;s Smoke-Free Business Revenue Jumps 15%, Raises Annual Profit Outlook</a></strong></p>
<p>Demand for new vehicles remained strong leading up to the tariff news, with a continued uptick in foot traffic into mid-April. </p>
<p>First-quarter gross profit per unit (GPU) is expected to hold steady or match fourth-quarter levels. Automakers appear to be adopting a wait-and-see approach to tariffs, with no immediate plans to increase vehicle prices.</p>
<p>In the ratings agency panel hosted by the analysts, S&amp;P classified both Ford and GM in the &#8220;High Risk&#8221; category, citing potential negative rating actions due to tariffs. </p>
<p>While Ford's BBB-/N rating might see a CreditWatch Negative status, S&amp;P's timeline for such action remains uncertain, with a potential downgrade expected by late 2025.</p>
<p>The panelists agreed that tariffs could cost OEMs $6,000 to $8,000 per car, with the risk of passing costs to consumers. They expressed concern over supply chain disruptions, particularly regarding parts under USMCA protections and China's control over rare materials like batteries.</p>
<p><strong>Read Next</strong>: </p>
<ul>
<li><a href="https://www.benzinga.com/25/04/44936972/vertiv-nvidia-igenius-launch-ai-supercomputer-project-in-italy"><strong>Vertiv, NVIDIA, iGenius Launch AI Supercomputer Project In Italy</strong></a></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Analyst Color

Analyst Ratings

General

APTV

LCID

PHIN

PSNY

RACE

RIVN

VWAGY

Automakers Are Struggling With Tariffs And EV Competition, Say Analysts

<ul>
<li>Digital and analog design flows on TSMC A16&#x2122; and N2P deliver optimized performance and rapid analog design migration, enabled by Synopsys.ai</li>
<li>Early collaboration on TSMC A14 process underway for Synopsys EDA flows development</li>
<li>Collaboration on 3Dblox and TSMC's CoWoS&#xAE; technologies for 5.5x reticle size packages, speeds integration of 3D stacked dies in next-generation AI chips</li>
<li>Broad portfolio of Synopsys Foundation and Interface IP provides the lowest power on TSMC's N2/N2P processes</li>
<li>Industry's most complete IP solutions for leading-edge standards, including HBM4, 1.6T Ethernet, UCIe, PCIe 7.0, and UALink, enable high-bandwidth interfaces in data-intensive heterogeneous SoCs</li>
</ul>


SNPS

Synopsys And TSMC Deliver EDA And IP Solutions

<p>NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-04-24. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that NovoCure will report an <strong>earnings per share</strong> (EPS) of $-0.49.</p>
<p>The market awaits NovoCure's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>In the previous earnings release, the company missed EPS by $0.27, leading to a 0.83% drop in the share price the following trading session.</p>
<p>Here's a look at NovoCure's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.34</td>
<td>-0.33</td>
<td>-0.41</td>
<td>-0.42</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.61</td>
<td>-0.28</td>
<td>-0.31</td>
<td>-0.36</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.0%</td>
<td>-11.0%</td>
<td>2.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745438583_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of NovoCure were trading at $16.51 as of April 22. Over the last 52-week period, shares are up 42.85%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Opinions on NovoCure</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding NovoCure.</p>
<p>The consensus rating for NovoCure is Neutral, derived from 3 analyst ratings. An average one-year price target of $29.67 implies a potential 79.71% upside.</p>
<h3>Comparing Ratings Among Industry Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of LeMaitre Vascular, Enovis and QuidelOrtho, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for LeMaitre Vascular, with an average 1-year price target of $105.0, suggesting a potential 535.98% upside.</li>
<li>Analysts currently favor an Buy trajectory for Enovis, with an average 1-year price target of $64.0, suggesting a potential 287.64% upside.</li>
<li>Analysts currently favor an Neutral trajectory for QuidelOrtho, with an average 1-year price target of $43.67, suggesting a potential 164.51% upside.</li>
</ul>
<h3>Insights: Peer Analysis</h3>
<p>Within the peer analysis summary, vital metrics for LeMaitre Vascular, Enovis and QuidelOrtho are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>NovoCure</td>
<td>Neutral</td>
<td>20.54%</td>
<td>$127.80M</td>
<td>-18.29%</td>
</tr>
<tr>
<td>LeMaitre Vascular</td>
<td>Buy</td>
<td>13.98%</td>
<td>$38.59M</td>
<td>3.35%</td>
</tr>
<tr>
<td>Enovis</td>
<td>Buy</td>
<td>23.29%</td>
<td>$307.52M</td>
<td>-23.87%</td>
</tr>
<tr>
<td>QuidelOrtho</td>
<td>Neutral</td>
<td>-4.69%</td>
<td>$326.10M</td>
<td>-5.78%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>NovoCure ranks at the top for Revenue Growth and Gross Profit among its peers. However, it ranks at the bottom for Return on Equity. Overall, NovoCure's performance is strong in terms of revenue and profit growth, but it lags behind in generating returns for its equity holders.</p>
<h3>About NovoCure</h3>
<p>NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.</p>
<h3>NovoCure's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> NovoCure's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>20.54%</strong>. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> NovoCure's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-40.88%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> NovoCure's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-18.29%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-5.35%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>1.9</strong>, NovoCure faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<p><a href="https://www.benzinga.com/quote/NVCR/earnings"><strong>To track all earnings releases for NovoCure visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


NVCR

NovoCure's Earnings: A Preview

<p>Goosehead Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.22 by 18.18 percent. This is a 7.14 percent decrease over earnings of $0.28 per share from the same period last year.  The company reported quarterly sales of $75.58 million which missed the analyst consensus estimate of $78.89 million by 4.20 percent.  This is a 17.26 percent increase over sales of $64.46 million the same period last year.</p>


Earnings Misses

Goosehead Insurance Q1 Adj. EPS $0.26 Beats $0.22 Estimate, Sales $75.58M Miss $78.89M Estimate

<p>West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTBA#NASDAQ">WTBA</a>) is preparing to release its quarterly earnings on Thursday, 2025-04-24. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect West Bancorp to report an <strong>earnings per share</strong> (EPS) of $0.38.</p>
<p>The announcement from West Bancorp is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat EPS by $0.02, which was followed by a 1.08% increase in the share price the next day.</p>
<p>Here's a look at West Bancorp's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.40</td>
<td>0.31</td>
<td>0.32</td>
<td>0.27</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.42</td>
<td>0.35</td>
<td>0.31</td>
<td>0.35</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745438573_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of West Bancorp were trading at $19.56 as of April 22. Over the last 52-week period, shares are up 19.42%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/WTBA/earnings"><strong>To track all earnings releases for West Bancorp visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


WTBA

Uncovering Potential: West Bancorp's Earnings Preview

<p>Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) is looking for Q2 GAAP EPS of $1.21-$1.47 vs $1.23 analyst estimate. sees sales of $4.170 billion-$4.530 billion vs $4.13 billion analyst estimate.</p>


Texas Instruments Sees Q2 GAAP EPS $1.21-$1.47 vs $1.23 Est; Sees Sales $4.170B-$4.530B vs $4.13B Est

<p>First Business Finl Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBIZ#NASDAQ">FBIZ</a>) is preparing to release its quarterly earnings on Thursday, 2025-04-24. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect First Business Finl Servs to report an <strong>earnings per share</strong> (EPS) of $1.21.</p>
<p>The market awaits First Business Finl Servs's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.17, which was followed by a 4.26% increase in the share price the next day.</p>
<p>Here's a look at First Business Finl Servs's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.26</td>
<td>1.19</td>
<td>1.09</td>
<td>1.12</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.43</td>
<td>1.24</td>
<td>1.23</td>
<td>1.04</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>4.0%</td>
<td>-4.0%</td>
<td>5.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745438560_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of First Business Finl Servs were trading at $48.65 as of April 22. Over the last 52-week period, shares are up 43.69%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/FBIZ/earnings"><strong>To track all earnings releases for First Business Finl Servs visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


FBIZ

Earnings Outlook For First Business Finl Servs

<p>USCB Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USCB#NASDAQ">USCB</a>) is preparing to release its quarterly earnings on Thursday, 2025-04-24. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect USCB Financial Holdings to report an <strong>earnings per share</strong> (EPS) of $0.38.</p>
<p>Investors in USCB Financial Holdings are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS missed by $0.03, leading to a 2.63% increase in the share price on the subsequent day.</p>
<p>Here's a look at USCB Financial Holdings's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.37</td>
<td>0.31</td>
<td>0.23</td>
<td>0.21</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.34</td>
<td>0.35</td>
<td>0.31</td>
<td>0.23</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>3.0%</td>
<td>-2.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745438547_0.png" alt="eps graph" /></p>
<h3>Performance of USCB Financial Holdings Shares</h3>
<p>Shares of USCB Financial Holdings were trading at $17.67 as of April 22. Over the last 52-week period, shares are up 77.95%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/USCB/earnings"><strong>To track all earnings releases for USCB Financial Holdings visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


USCB

Examining the Future: USCB Financial Holdings's Earnings Outlook

<p>Ladder Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LADR#NYSE">LADR</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-04-24. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Ladder Cap will report an <strong>earnings per share</strong> (EPS) of $0.24.</p>
<p>Anticipation surrounds Ladder Cap's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Historical Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS missed by $0.01, leading to a 0.51% increase in the share price on the subsequent day.</p>
<p>Here's a look at Ladder Cap's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.28</td>
<td>0.26</td>
<td>0.30</td>
<td>0.29</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.27</td>
<td>0.30</td>
<td>0.31</td>
<td>0.33</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>1.0%</td>
<td>-1.0%</td>
<td>0.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745438538_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Ladder Cap were trading at $10.17 as of April 22. Over the last 52-week period, shares are down 5.6%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/LADR/earnings"><strong>To track all earnings releases for Ladder Cap visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


LADR

A Preview Of Ladder Cap's Earnings

<p><i><strong>AI-based workflows aid advanced node designs, ensuring design and system technology co-optimization for HPC and AI applications</strong></i></p>
<p>/&nbsp;<strong>Key Highlights&nbsp;</strong></p>
<ul>
<li>TSMC and Ansys advance AI-assisted workflows to support design optimization during technology node migration and photonic design optimization with TSMC's Compact Universal Photonic Engine (COUPE) platform</li>
<li><a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4411586-1&amp;h=3997906458&amp;u=https%3A%2F%2Fansys.me%2F4izIuOv&amp;a=Ansys+RedHawk-SC%E2%84%A2">Ansys RedHawk-SC&#x2122;</a>&nbsp;and <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4411586-1&amp;h=3800937999&amp;u=https%3A%2F%2Fansys.me%2F4jNZr8N&amp;a=Ansys+Totem%E2%84%A2">Ansys Totem&#x2122;</a>&nbsp;power integrity and electromigration reliability platforms and <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4411586-1&amp;h=1625743486&amp;u=https%3A%2F%2Fansys.me%2F42Xvspk&amp;a=Ansys+RedHawk-SC-Electrothermal%E2%84%A2">Ansys RedHawk-SC-Electrothermal&#x2122;</a> multiphysics platform are certified for TSMC's latest A16&#x2122; process</li>
<li>Ansys HFSS-IC Pro system-on-chip (SoC) electromagnetic solution is certified for TSMC's 5nm and 3nm process</li>
</ul>
<p>PITTSBURGH, April 23, 2025 /PRNewswire/ -- Through continued collaboration with TSMC, <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4411586-1&amp;h=3234318169&amp;u=https%3A%2F%2Fwww.ansys.com%2F&amp;a=Ansys">Ansys</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANSS#NASDAQ">ANSS</a>)&nbsp;today announced enhanced AI-assisted workflows for radio frequency (RF) design migration and photonic integrated circuits (PICs), and new certifications for its semiconductor solutions. Together, Ansys and TSMC facilitate optimized 3D integrated circuit (3D-IC) design and accelerate market readiness for AI and high-performance computing (HPC) chip applications. Ansys and TSMC are also extending tool certification for the newly announced N3C technology, based on available N3P design solutions.</p>


ANSS

Ansys Strengthens Collaboration With TSMC On Advanced Node Processes Certification And 3D Integrated Circuit Multiphysics Design Solutions

<p><strong>Knowles</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KN#NYSE">KN</a>) is set to give its latest quarterly earnings report on Thursday, 2025-04-24. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Knowles will report an <strong>earnings per share</strong> (EPS) of $0.18. </p>
<p>Anticipation surrounds Knowles's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company missed EPS by $0.01, which was followed by a 0.22% increase in the share price the next day.</p>
<p>Here's a look at Knowles's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.28</td>
<td>0.26</td>
<td>0.24</td>
<td>0.18</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.27</td>
<td>0.26</td>
<td>0.24</td>
<td>0.20</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>3.0%</td>
<td>-3.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745438528_0.png" alt="eps graph" /></p>
<h3>Performance of Knowles Shares</h3>
<p>Shares of Knowles were trading at $14.4 as of April 22. Over the last 52-week period, shares are down 6.86%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/KN/earnings"><strong>To track all earnings releases for Knowles visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


What to Expect from Knowles's Earnings

<p>Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) is preparing to release its quarterly earnings on Thursday, 2025-04-24. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Gentherm to report an <strong>earnings per share</strong> (EPS) of $0.46.</p>
<p>The market awaits Gentherm's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>Last quarter the company missed EPS by $0.39, which was followed by a 0.3% increase in the share price the next day.</p>
<p>Here's a look at Gentherm's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.68</td>
<td>0.66</td>
<td>0.61</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.29</td>
<td>0.75</td>
<td>0.66</td>
<td>0.62</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>0.0%</td>
<td>-1.0%</td>
<td>-2.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745438513_0.png" alt="eps graph" /></p>
<h3>Performance of Gentherm Shares</h3>
<p>Shares of Gentherm were trading at $24.49 as of April 22. Over the last 52-week period, shares are down 50.47%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<h3>Analyst Insights on Gentherm</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Gentherm.</p>
<p>The consensus rating for Gentherm is Neutral, based on 3 analyst ratings. With an average one-year price target of $39.0, there's a potential 59.25% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>The analysis below examines the analyst ratings and average 1-year price targets of Fox Factory Holding, Adient and American Axle &amp; Mfg Hldgs, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Fox Factory Holding, with an average 1-year price target of $30.6, suggesting a potential 24.95% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Adient, with an average 1-year price target of $16.57, suggesting a potential 32.34% downside.</li>
<li>Analysts currently favor an Neutral trajectory for American Axle &amp; Mfg Hldgs, with an average 1-year price target of $5.7, suggesting a potential 76.73% downside.</li>
</ul>
<h3>Snapshot: Peer Analysis</h3>
<p>The peer analysis summary outlines pivotal metrics for Fox Factory Holding, Adient and American Axle &amp; Mfg Hldgs, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gentherm</td>
<td>Neutral</td>
<td>-3.82%</td>
<td>$86.10M</td>
<td>2.40%</td>
</tr>
<tr>
<td>Fox Factory Holding</td>
<td>Buy</td>
<td>6.12%</td>
<td>$101.98M</td>
<td>-0.01%</td>
</tr>
<tr>
<td>Adient</td>
<td>Neutral</td>
<td>-4.51%</td>
<td>$216M</td>
<td>0.00%</td>
</tr>
<tr>
<td>American Axle &amp; Mfg Hldgs</td>
<td>Neutral</td>
<td>-5.62%</td>
<td>$154.30M</td>
<td>-2.24%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Gentherm ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit and Return on Equity.</p>
<h3>All You Need to Know About Gentherm</h3>
<p>Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.</p>
<h3>Gentherm: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Challenges:</strong> Gentherm's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately <strong>-3.82%</strong>. This indicates a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>4.34%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Gentherm's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>2.4%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Gentherm's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.2%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.43</strong>, Gentherm adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/THRM/earnings"><strong>To track all earnings releases for Gentherm visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


THRM

A Peek at Gentherm's Future Earnings

<p>Churchill Downs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHDN#NASDAQ">CHDN</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $1.01 by 5.94 percent. This is a 5.31 percent decrease over earnings of $1.13 per share from the same period last year.  The company reported quarterly sales of $642.60 million which beat the analyst consensus estimate of $642.17 million by 0.07 percent.  This is a 8.75 percent increase over sales of $590.90 million the same period last year.</p>


CHDN

Churchill Downs Q1 Adj. EPS $1.07 Beats $1.01 Estimate, Sales $642.60M Beat $642.17M Estimate

<p>Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) reported quarterly earnings of $1.28 per share which beat the analyst consensus estimate of $1.07 by 19.63 percent. This is a 16.36 percent increase over earnings of $1.10 per share from the same period last year.  The company reported quarterly sales of $4.07 billion which beat the analyst consensus estimate of $3.91 billion by 4.04 percent.  This is a 11.14 percent increase over sales of $3.66 billion the same period last year.</p>


Texas Instruments Q1 EPS $1.28 Beats $1.07 Estimate, Sales $4.07B Beat $3.91B Estimate

<p>OceanFirst Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCFC#NASDAQ">OCFC</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-04-24. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that OceanFirst Financial will report an <strong>earnings per share</strong> (EPS) of $0.35.</p>
<p>The market awaits OceanFirst Financial's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company beat EPS by $0.01, leading to a 1.78% drop in the share price the following trading session.</p>
<p>Here's a look at OceanFirst Financial's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.37</td>
<td>0.38</td>
<td>0.43</td>
<td>0.41</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.38</td>
<td>0.39</td>
<td>0.39</td>
<td>0.44</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-2.0%</td>
<td>-2.0%</td>
<td>-5.0%</td>
<td>4.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745438490_0.png" alt="eps graph" /></p>
<h3>Market Performance of OceanFirst Financial's Stock</h3>
<p>Shares of OceanFirst Financial were trading at $16.22 as of April 22. Over the last 52-week period, shares are up 7.42%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/OCFC/earnings"><strong>To track all earnings releases for OceanFirst Financial visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Comments

Abound Energy

Actualités

Dernières nouvelles pour Abound Energy (OTC:ZAIRF) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL